Medicare utilization — MICHELLE ALYCE JAHNKE (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| 17003 | Destruction of precancer skin growth, 2-14 growths | 957 | 224 | $0 | $4,357 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 627 | 546 | $0 | $34,463 |
| 17000 | Destruction of precancer skin growth, 1 growth | 430 | 356 | $0 | $15,418 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 339 | 37 | $0 | $231 |
| 11102 | Biopsy of related skin growth, first growth | 292 | 243 | $0 | $16,951 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·